Quick Answer
Phio Pharmaceuticals Corp. reported Operating Income of -$9.22 million for fiscal year 2025.
Phio Pharmaceuticals Corp. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$9.22M | -24.8% |
| 2024 | -$7.39M | +31.8% |
| 2023 | -$10.82M | +5.6% |
| 2022 | -$11.46M | +15.2% |
| 2021 | -$13.51M | -53.7% |
| 2020 | -$8.79M | +2.2% |
| 2019 | -$8.99M | -22.0% |
| 2018 | -$7.36M | +47.6% |
| 2017 | -$14.06M | -56.0% |
| 2016 | -$9.02M | +11.9% |
| 2015 | -$10.24M | -16.0% |
| 2014 | -$8.83M | +57.9% |
| 2013 | -$20.95M | -61.5% |
| 2012 | -$12.97M | -1.6% |
| 2011 | -$12.77M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.50M | -57.5% | -8.5% |
| June 30, 2025 | -$2.31M | -20.6% | -23.3% |
| March 31, 2025 | -$1.87M | +15.3% | -17.7% |
| September 30, 2024 | -$1.59M | +42.7% | +16.9% |
| June 30, 2024 | -$1.91M | +24.9% | +13.4% |
| March 31, 2024 | -$2.21M | +38.7% | +20.4% |
| September 30, 2023 | -$2.78M | +22.3% | -9.0% |
| June 30, 2023 | -$2.55M | -1.0% | +29.3% |
- Phio Pharmaceuticals Corp. showed a decrease of -24.8% in Operating Income compared to the prior fiscal year.
- Over the 2011–2025 period, Phio Pharmaceuticals Corp.’s operating income has grown by 27.8% (from -$12.77 million to -$9.22 million).
- The most recent figure is from Phio Pharmaceuticals Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: